Arguments for a different regulatory categorization and framework for stromal vascular fraction.
STEM CELLS AND DEVELOPMENT(2020)
Abstract
Although adipose tissue and cells show considerable promise for clinical translation in the emerging field of regenerative medicine, they present a challenge to the regulatory community both nationally and internationally. This commentary evaluates the status of adipose-derived therapeutics and considers regulatory approaches designed to maximize patient safety while advancing clinical translation in accordance with evidence-based medical science.
MoreTranslated text
Key words
cell therapy,regenerative medicine,adipose-derived stromal,stem cells,stromal vascular fraction cells,regulation
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined